Get the Stockscreener App
23.78
1.03%
-0.1765
Surrozen Inc stock is traded at $23.78, with a volume of 122.37K.
It is down -1.03% in the last 24 hours and up +7.98% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
See More
Previous Close:
$23.96
Open:
$23.85
24h Volume:
122.37K
Relative Volume:
0.66
Market Cap:
$280.09M
Revenue:
$7.49M
Net Income/Loss:
$-360.50M
P/E Ratio:
-0.5756
EPS:
-41.3227
Net Cash Flow:
$-33.68M
1W Performance:
-5.49%
1M Performance:
+7.98%
6M Performance:
-3.33%
1Y Performance:
+112.86%
1-Day Range:
$23.25
$24.96
1-Week Range:
$22.84
$25.80
52-Week Range:
$10.11
$35.00
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
23.83 | 281.62M | 7.49M | -360.50M | -33.68M | -41.32 |
VRTX
Vertex Pharmaceuticals Inc
|
515.76 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.65 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.87 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.83 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.63 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Initiated | TD Cowen | Buy |
| Feb-19-26 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
View All
Surrozen Inc Stock (SRZN) Latest News
Braidwell group reports 3.9% Surrozen (SRZN) holding in amended 13G filing - Stock Titan
Surrozen (SRZN): Boxer Capital group discloses 8.9% ownership stake in 13G/A - Stock Titan
Liquidity Mapping Around (SRZN) Price Events - Stock Traders Daily
StemPoint Capital reports 5.0% Surrozen (SRZN) stake via shares and warrants - Stock Titan
Analysts Just Made A Massive Upgrade To Their Surrozen, Inc. (NASDAQ:SRZN) Forecasts - simplywall.st
What is HC Wainwright's Estimate for Surrozen Q3 Earnings? - MarketBeat
Surrozen (SRZN): 5AM Ventures group reports 7.8% beneficial ownership stake - Stock Titan
Surrozen: Buy Rating Reiterated as Clinical Roadmap Clarifies and IP Strengthens; Price Target Maintained at $44 - TipRanks
HC Wainwright Reiterates "Buy" Rating for Surrozen (NASDAQ:SRZN) - MarketBeat
H.C. Wainwright reiterates Surrozen stock rating at buy, $44 target - Investing.com India
Surrozen Inc (SRZN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Surrozen (SRZN) warrants expiring 2026 removed from Nasdaq listing - Stock Titan
Surrozen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Surrozen earnings beat by $0.88, revenue topped estimates - Investing.com Canada
Surrozen (NASDAQ:SRZN) Issues Quarterly Earnings Results, Beats Expectations By $0.88 EPS - MarketBeat
Surrozen, Inc. 2Q 2026: Revenue $5M, Net income $50.18M, EPS $(0.41) — 10-Q Summary - TradingView
Surrozen (NASDAQ: SRZN) swings to $50.2M profit on Boehringer milestone revenue - Stock Titan
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance
Surrozen, Inc. expected to post a loss of $1.29 a shareEarnings Preview - TradingView
Why (SRZN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Perceptive Advisors LLC Makes New $6.68 Million Investment in Surrozen, Inc. $SRZN - MarketBeat
Surrozen Inc. Warrant (SRZNW) Holds at $0.01 as Trading Remains FlatMACD Signal Stocks - dars.gov.et
Price to earnings forward of Surrozen, Inc. – BOATS:SRZNW - TradingView
Surrozen (NASDAQ:SRZN) Upgraded by Zacks Research to Hold Rating - MarketBeat
Surrozen, Inc. Revenue Breakdown – NASDAQ:SRZN - TradingView
Insider Selling: Surrozen (NASDAQ:SRZN) Major Shareholder Sells 325,000 Shares of Stock - MarketBeat
Surrozen Inc (SRZN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Surrozen Inc (SRZN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Surrozen Inc (SRZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Surrozen Inc (SRZN) Cash Flow - TradingKey
SRZN|Surrozen Inc|Price:25.620|Chg%:+3.980 - TradingKey
SRZN|Surrozen Inc|Price:19.660|Chg%:-0.070 - TradingKey
Surrozen Inc (SRZN) Income Statement - TradingKey
TCG Crossover sells 325,000 Surrozen shares for $6.91 million - Bitget
Form 4 Surrozen Inc For: 24 July By Investing.com - Investing.com South Africa
TCG Crossover GP II sells $6.9 million in Surrozen shares By Investing.com - Investing.com Canada
TCG Crossover GP II sells $6.9 million in Surrozen shares - Investing.com
Surrozen (SRZN): TCG Crossover funds, Chen Yu disclose 9.9% stake - Stock Titan
SRZN|Surrozen Inc|Price:21.170|Chg%:-0.550 - TradingKey
Understanding Momentum Shifts in (SRZN) - Stock Traders Daily
Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright - Yahoo Finance
Surrozen at H.C. Wainwright ophthalmology conference: eyeing multi-target edge - Investing.com Canada
Surrozen Inc. (SRZN) Gains 3.75% as Shares Approach Key Resistance at $24.14PCR Spike - dars.gov.et
SRZN Q1 2026 Earnings: Wider-than-Expected Loss Amid Clinical ProgressNext Quarter Guidance - po-news-eg.net
Surrozen to Present at Upcoming Healthcare Investor Conference - Sahm
Surrozen to present at H.C. Wainwright Ophthalm... - Pluang
Surrozen Sets Fireside Chat at Virtual Ophthalmology Conference - Stock Titan
Surrozen Inc. (SRZN) Q1 2026 Earnings: Massive EPS Miss as Pre-Revenue Biotech Continues Cash BurnProfit Growth Outlook - dars.gov.et
Surrozen Inc Warrant 2026-01.08.31 on Surrozen Financial Disclosures & SEC Filings - TradingView
Price to sales forward of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Price to book forward of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surrozen Inc Stock (SRZN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research |
May 04 '26 |
Sale |
33.33 |
1,584 |
52,799 |
17,216 |
| Williams Charles O | Chief Operating Officer |
May 04 '26 |
Sale |
33.33 |
2,036 |
67,866 |
16,571 |
| Parker Craig C | Chief Executive Officer |
May 04 '26 |
Sale |
33.33 |
4,524 |
150,798 |
16,553 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 24 '26 |
Buy |
24.69 |
106,658 |
2,633,717 |
736,554 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 23 '26 |
Buy |
24.90 |
15,223 |
379,051 |
683,225 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 13 '26 |
Buy |
24.88 |
35,433 |
881,463 |
675,018 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 12 '26 |
Buy |
24.99 |
12,374 |
309,166 |
657,301 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 16 '26 |
Buy |
24.99 |
1,190 |
29,733 |
675,613 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 11 '26 |
Buy |
23.57 |
17,763 |
418,763 |
650,567 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 12 '26 |
Buy |
23.86 |
1,093 |
26,082 |
651,114 |
3.00%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):